Company Filing History:
Years Active: 2014-2019
Title: Michel Fons: Innovator in Antimicrobial Peptides
Introduction
Michel Fons is a notable inventor based in Aix en Provence, France. He has made significant contributions to the field of antimicrobial peptides, holding a total of 2 patents. His work focuses on innovative solutions that address microbial resistance, which is a growing concern in various industries.
Latest Patents
Fons' latest patents include several strains with antimicrobial activity. These strains, designated as Anstrain, include AP1, AP2, AP3, and AP4, all filed with DSMZ on February 19, 2014, under the respective numbers DSM 28444, DSM 28445, DSM 28446, and DSM 28447. Additionally, he has developed RumC peptides, specifically RumC1, RumC2, and RumC3, which exhibit antimicrobial properties. These peptides are encoded by genes isolated from E1, showcasing Fons' innovative approach to combating microbial threats.
Career Highlights
Michel Fons is currently associated with Adisseo France Sas, where he continues to advance his research and development efforts. His work has positioned him as a key player in the field of antimicrobial research, contributing to the development of effective solutions for various applications.
Collaborations
Fons collaborates with talented individuals such as Ange Pujol and Caroline Mirande, enhancing the innovative capacity of his projects. Their combined expertise fosters a collaborative environment that drives forward-thinking research.
Conclusion
Michel Fons is a distinguished inventor whose work in antimicrobial peptides is paving the way for new solutions in the fight against microbial resistance. His contributions are vital to the ongoing efforts in this critical area of research.